Form 8-K - Current report:
SEC Accession No. 0001193125-16-786870
Filing Date
2016-12-07
Accepted
2016-12-07 07:26:02
Documents
3
Period of Report
2016-12-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d279613d8k.htm 8-K 15457
2 EX-99.1 d279613dex991.htm EX-99.1 17997
3 GRAPHIC g279613g1206143457442.jpg GRAPHIC 2987
  Complete submission text file 0001193125-16-786870.txt   39041
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Filer) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33882 | Film No.: 162037616
SIC: 8731 Services-Commercial Physical & Biological Research